Zogenix - ZGNX Stock Forecast, Price & News

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zogenix in the last twelve months. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ZGNX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZGNX, but not buy additional shares or sell existing shares.
View ZGNX analyst ratings or view top-rated stocks.

7 analysts have issued 12-month price objectives for Zogenix's shares. Their ZGNX share price forecasts range from $23.00 to $62.00. On average, they expect the company's share price to reach $35.75 in the next twelve months. This suggests a possible upside of 34.0% from the stock's current price.
View analysts price targets for ZGNX or view top-rated stocks among Wall Street analysts.

Zogenix, Inc. (NASDAQ:ZGNX) released its earnings results on Thursday, November, 4th. The company reported ($1.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.96) by $0.08. The business had revenue of $22.61 million for the quarter, compared to analyst estimates of $22.71 million. Zogenix had a negative trailing twelve-month return on equity of 91.20% and a negative net margin of 278.38%. The company's quarterly revenue was up 690.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($1.02) EPS.

7 employees have rated Zogenix Chief Executive Officer Stephen Farr, Ph.D. on Glassdoor.com. Stephen Farr, Ph.D. has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Zogenix investors own include GW Pharmaceuticals (GWPH), Gilead Sciences (GILD), Vanda Pharmaceuticals (VNDA), AbbVie (ABBV), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Southwest Airlines (LUV) and Micron Technology (MU).

Zogenix trades on the NASDAQ under the ticker symbol "ZGNX."

One share of ZGNX stock can currently be purchased for approximately $26.68.

Zogenix (NASDAQ:ZGNX) has a market capitalization of $1.50 billion and generates $81.69 million in revenue each year. The company earns $-209,380,000.00 in net income (profit) each year or ($4.07) on an earnings per share basis.

Zogenix employs 218 workers across the globe.

Zogenix's mailing address is 5959 Horton Street Suite 500, EMERYVILLE CA, 94608. The official website for the company is www.zogenix.com. The company can be reached via phone at (510) 550-8300, via email at ir@zogenix.com, or via fax at 858-259-1166.